These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15248163)

  • 1. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to tinidazole.
    Brorson O; Brorson SH
    Int Microbiol; 2004 Jun; 7(2):139-42. PubMed ID: 15248163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to hydroxychloroquine.
    Brorson O; Brorson SH
    Int Microbiol; 2002 Mar; 5(1):25-31. PubMed ID: 12102233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole.
    Brorson O; Brorson SH
    APMIS; 1999 Jun; 107(6):566-76. PubMed ID: 10379684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of motile and cystic forms of Borrelia burgdorferi to ranitidine bismuth citrate.
    Brorson O; Brorson SH
    Int Microbiol; 2001 Dec; 4(4):209-15. PubMed ID: 12051564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro study of the activity of telithromycin against mobile and cystic forms of Borrelia afzelii.
    Brorson Ø; Brorson SH
    Infection; 2006 Feb; 34(1):26-8. PubMed ID: 16501899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi.
    Sapi E; Kaur N; Anyanwu S; Luecke DF; Datar A; Patel S; Rossi M; Stricker RB
    Infect Drug Resist; 2011; 4():97-113. PubMed ID: 21753890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persister Development by Borrelia burgdorferi Populations In Vitro.
    Caskey JR; Embers ME
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6288-95. PubMed ID: 26248368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium.
    Brorson O; Brorson SH
    Infection; 1998; 26(3):144-50. PubMed ID: 9646104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto.
    Sicklinger M; Wienecke R; Neubert U
    J Clin Microbiol; 2003 Apr; 41(4):1791-3. PubMed ID: 12682190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibilities of Leptospira spp. and Borrelia burgdorferi isolates to amoxicillin, tilmicosin, and enrofloxacin.
    Kim D; Kordick D; Divers T; Chang YF
    J Vet Sci; 2006 Dec; 7(4):355-9. PubMed ID: 17106227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes.
    Brorson O; Brorson SH
    Infection; 1997; 25(4):240-6. PubMed ID: 9266264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid method for generating cystic forms of Borrelia burgdorferi, and their reversal to mobile spirochetes.
    Brorson O; Brorson SH
    APMIS; 1998 Dec; 106(12):1131-41. PubMed ID: 10052721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human neutrophil calprotectin reduces the susceptibility of Borrelia burgdorferi to penicillin.
    Montgomery RR; Schreck K; Wang X; Malawista SE
    Infect Immun; 2006 Apr; 74(4):2468-72. PubMed ID: 16552081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline.
    Brorson Ø; Brorson SH; Scythes J; MacAllister J; Wier A; Margulis L
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18656-61. PubMed ID: 19843691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of tigecycline against multiple strains of Borrelia burgdorferi.
    Yang X; Nguyen A; Qiu D; Luft BJ
    J Antimicrob Chemother; 2009 Apr; 63(4):709-12. PubMed ID: 19182236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening.
    Pothineni VR; Wagh D; Babar MM; Inayathullah M; Solow-Cordero D; Kim KM; Samineni AV; Parekh MB; Tayebi L; Rajadas J
    Drug Des Devel Ther; 2016; 10():1307-22. PubMed ID: 27103785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cystic forms by different stress conditions in Borrelia burgdorferi.
    Murgia R; Cinco M
    APMIS; 2004 Jan; 112(1):57-62. PubMed ID: 14961976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates.
    Hunfeld KP; Kraiczy P; Wichelhaus TA; Schäfer V; Brade V
    Int J Antimicrob Agents; 2000 Jun; 15(1):11-7. PubMed ID: 10856671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythromycin resistance in Borrelia burgdorferi.
    Terekhova D; Sartakova ML; Wormser GP; Schwartz I; Cabello FC
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3637-40. PubMed ID: 12384380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal Activity of Octenidine to Various Genospecies of Borrelia burgdorferi, Sensu Lato Spirochetes in Vitro and in Vivo.
    Tylewska-Wierzbanowska S; Rogulska U; Lewandowska G; Chmielewski T
    Pol J Microbiol; 2017 Jul; 66(2):259-263. PubMed ID: 28735308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.